In vivo antitumour properties of tribenzyltin carboxylates in a 4T1 murine metastatic mammary tumour model: Enhanced efficacy by PLGA nanoparticles

Acharya, 2011, PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect, Adv. Drug Deliv. Rev., 63, 170, 10.1016/j.addr.2010.10.008 Alama, 2009, In vitro cytotoxic activity of tri-n-butyltin(IV) lupinylsulfide hydrogen fumarate (IST-FS 35) and preliminary antitumour activity in vivo, Invest. New Drugs, 27, 124, 10.1007/s10637-008-9148-x Anasamy, 2017, Tribenzyltin carboxylates as anticancer drug candidates: effect on the cytotoxicity, motility and invasiveness of breast cancer cell lines, Eur. J. Med. Chem., 125, 770, 10.1016/j.ejmech.2016.09.061 Arnold, 2005, Effect of repetitive administration of doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumour model, Clin. Cancer Res., 11, 8856, 10.1158/1078-0432.CCR-05-1365 Baalousha, 2012, Rationalizing nanomaterial sizes measured by atomic force microscopy, flow field-flow fractionation, and dynamic light scattering: sample preparation, polydispersity, and particle structure, Environ. Sci. Technol., 46, 6134, 10.1021/es301167x Bergamo, 2010, In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model, J. Inorg. Biochem., 104, 79, 10.1016/j.jinorgbio.2009.10.005 Binder, 2013, Evolution of taxanes in the treatment of metastatic breast cancer, Clin. J. Oncol. Nurs., 17, 9, 10.1188/13.CJON.S1.9-14 Bowerman, 2017, Docetaxel-loaded PLGA nanoparticles improve efficacy in taxane-resistant triple-negative breast cancer, Nano Lett., 17, 242, 10.1021/acs.nanolett.6b03971 Bulatovic, 2014, Organotin(IV)-loaded mesoporous silica as a biocompatible strategy in cancer treatment, Angew. Chem. Int. Ed. Engl., 53, 5982, 10.1002/anie.201400763 Chen, 2007, CHAPTER 21 - Pharmacological Differences between men and women, 325 Danhier, 2012, PLGA-based nanoparticles: an overview of biomedical applications, J. Controlled Release, 161, 505, 10.1016/j.jconrel.2012.01.043 Deryabin, 2015, A zeta potential value determines the aggregate's size of penta-substituted[60]fullerene derivatives in aqueous suspension whereas positive charge is required for toxicity against bacterial cells, J. Nanobiotechnol., 13, 50, 10.1186/s12951-015-0112-6 Duan, 2012, Area under the curve as a tool to measure kinetics of tumour growth in experimental animals, J. Immunol. Methods, 382, 224, 10.1016/j.jim.2012.06.005 Etaiw, 2011, A novel hydrogen bonded bimetallic supramolecular coordination polymer {[SnMe3(bpe)][Ag(CN)2]•2H2O} as anticancer drug, Eur. J. Med. Chem., 46, 5370, 10.1016/j.ejmech.2011.08.041 Gaillard, 2014, Blood-to-brain drug delivery using nanocarriers, 433 Gao, 2008, Risk factors for initial lung metastasis from breast invasive ductal carcinoma in stages I–III of operable patients, Jpn. J. Clin. Oncol., 39, 97, 10.1093/jjco/hyn133 Göschl, 2017, Comparative studies of oxaliplatin-based platinum(IV) complexes in different in vitro and in vivo tumour models, Metallomics, 9, 309, 10.1039/C6MT00226A Harper, 2017, Synthesis, characterization and in vitro and in vivo anticancer activity of pt(iv) derivatives of [Pt(1S,2S-DACH)(5, 6-dimethyl-1,10-phenanthroline)], Dalton Trans., 46, 7005, 10.1039/C7DT01054K Kai, 2015, Evaluation of drug loading, pharmacokinetic behavior, and toxicity of a cisplatin-containing hydrogel nanoparticle, J. Controlled Release, 204, 70, 10.1016/j.jconrel.2015.03.001 Koudelka, 2010, Liposomes with high encapsulation capacity for paclitaxel: preparation, characterisation and in vivo anticancer effect, J. Pharm. Sci., 99, 2309, 10.1002/jps.21992 Kue, 2014, Targeted PDT agent eradicates TRKC expressing tumours via photodynamic therapy (PDT), Mol. Pharm., 12, 212, 10.1021/mp5005564 Kue, 2016, Tropomyosin receptor kinase C targeted delivery of a peptidomimetic ligand-photosensitizer conjugate induces antitumour immune responses following photodynamic therapy, Sci. Rep., 6, 37209, 10.1038/srep37209 Kumari, 2010, Biodegradable polymeric nanoparticles-based drug delivery systems, Colloids Surf. B, 75, 1, 10.1016/j.colsurfb.2009.09.001 Li, 2015, Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasis, Acta. Biomater., 18, 132, 10.1016/j.actbio.2015.02.022 Lu, 2013, Polymeric micelles and alternative nano sized delivery vehicles for poorly soluble drugs, Int. J. Pharm., 453, 198, 10.1016/j.ijpharm.2012.08.042 Maeda, 2009, Polymeric drugs for efficient tumour-targeted drug delivery based on EPR-effect, Eur. J. Pharm. Biopharm., 71, 409, 10.1016/j.ejpb.2008.11.010 Mattheolabakis, 2009, In vivo investigation of tolerance and antitumour activity of cisplatin-loaded PLGA-MPEG nanoparticles, Eur. J. Pharm. Biopharm., 71, 190, 10.1016/j.ejpb.2008.09.011 Mhlanga, 2015, Kinetic models for the release of the anticancer drug doxorubicin from biodegradable polylactide/metal oxide-based hybrids, Int. J. Biol. Macromol., 72, 1301, 10.1016/j.ijbiomac.2014.10.038 Murdock, 2008, Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique, Toxicol. Sci., 101, 239, 10.1093/toxsci/kfm240 Navakoski de Oliveira, 2014, Organotin complexes containing carboxylate ligands with maleimide and naphthalimide derived partial structures: TrxR inhibition, cytotoxicity and activity in resistant cancer cells, Eur. J. Med. Chem., 87, 794, 10.1016/j.ejmech.2014.09.075 Öztürk-Atar, 2017, Novel advances in targeted drug delivery, J. Drug Target., 26, 633, 10.1080/1061186X.2017.1401076 Park, 2010, Targeted delivery of low molecular drugs using chitosan and its derivatives, Adv. Drug Deliv. Rev., 62, 28, 10.1016/j.addr.2009.10.003 Saneja, 2017, Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumour efficacy, Int. J. Pharm., 531, 153, 10.1016/j.ijpharm.2017.08.076 Sirajuddin, 2016, Organotin(IV) carboxylates as promising potential drug candidates in the field of cancer chemotherapy, Curr. Pharm. Des., 22, 6665, 10.2174/1381612822666160906143249 ten Tije, 2003, Pharmacological effects of formulation vehicles: implications for cancer chemotherapy, Clin. Pharmacokinet., 42, 665, 10.2165/00003088-200342070-00005 Varela-Ramirez, 2011, Cytotoxic effects of two organotin compounds and their mode of inflicting cell death on four mammalian cancer cells, Cell. Biol. Toxicol., 27, 159, 10.1007/s10565-010-9178-y Verginadis, 2011, Anticancer and cytotoxic effects of a triorganotin compound with 2-mercapto-nicotinic acid in malignant cell lines and tumour bearing Wistar rats, Eur. J. Pharm. Sci., 42, 253, 10.1016/j.ejps.2010.11.015 Voon, 2016, Chitosan-coated poly(lactic-co-glycolic acid)-diiodinated boron-dipyrromethene nanoparticles improve tumour selectivity and stealth properties in photodynamic cancer therapy, J. Biomed. Nanotechnol., 12, 1431, 10.1166/jbn.2016.2263 Wehbe, 2018, Development of a copper-clioquinol formulation suitable for intravenous use, Drug Deliv. Transl. Res., 2018, 1 Weiss, 1990, Hypersensitivity reactions from taxol, J. Clin. Oncol., 8, 1263, 10.1200/JCO.1990.8.7.1263 Xiong, 2012, A poly(γ, l-glutamic acid)-citric acid based nanoconjugate for cisplatin delivery, Biomaterials, 33, 7182, 10.1016/j.biomaterials.2012.06.071 Yallapu, 2010, Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells, J. Colloid Interface Sci., 351, 19, 10.1016/j.jcis.2010.05.022 Yokoyama, 1991, Toxicity and antitumour activity against solid tumours of micelle-forming polymeric anticancer drug and its extremely long circulation in blood, Cancer Res., 51, 3229